Rectal Cancer Stage III Clinical Trials

22 clinical trials for Rectal Cancer Stage III across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial — RECRUITING · NA
• Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression — RECRUITING · PHASE2
• The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial — RECRUITING · NA
• Bovine Reinforcement in Stomach, Colorectal and Lung Operation — RECRUITING · PHASE3
• ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer — RECRUITING
• The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer — RECRUITING · PHASE2
• UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer — RECRUITING · PHASE4
• Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer — NOT_YET_RECRUITING
• Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients — ACTIVE_NOT_RECRUITING · PHASE3
• Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer — COMPLETED · PHASE2
• TNT to Increase the Clinical Complete Response Rate for Distal LARC — ACTIVE_NOT_RECRUITING · PHASE2
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• Sentinel Lymph Node Biopsy in Rectal Cancer — OTHER · NA
• Using Artificial Intelligence to Predict Rectal Cancer Outcomes — COMPLETED
• "Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study". — COMPLETED
• The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer — OTHER
• Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer — OTHER
• Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. — OTHER · PHASE2
• Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma — COMPLETED

Refine this search